A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)

Recruiting now · Phase 1/Phase 2

Conditions studied: LMNA-Related Dilated Cardiomyopathy

In brief

This study is designed to evaluate the safety and tolerability of NVC-001 in adults with LMNA-related dilated cardiomyopathy (LMNA-DCM). The study will also assess exploratory measures of efficacy.

Key facts

Study ID

NCT07606274

Run by

Nuevocor Pte. Ltd.

People needed

21

Starts

2026-06-16

Expected to finish

2030-03-01

Last updated by the study team

2026-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Houston Methodist Hospital — Houston, Texas, United States (enrolling)
• Cedars-Sinai Medical Center — Los Angeles, California, United States (enrolling)
• Mayo Clinic — Rochester, Minnesota, United States (enrolling)
• University of Michigan — Ann Arbor, Michigan, United States
• University of Alabama in Birmingham — Birmingham, Alabama, United States
• The Christ Hospital — Cincinnati, Ohio, United States
• The Ohio State University — Columbus, Ohio, United States
• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.